Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myo-inositol-dependent neuronal signalling refers to the cellular processes in neurons that rely on myo-inositol, a carbocyclic sugar alcohol, as a key molecule for signal transduction and synaptic function. Myo-inositol serves as a precursor for phosphoinositides and other inositol-containing compounds that are essential for neuronal development, synaptic activity, and plasticity. Neurons depend on myo-inositol uptake from the extracellular environment via specific transporters such as HMIT. Upon neuronal activation, HMIT is translocated to the plasma membrane, increasing myo-inositol uptake necessary for sustained signalling. Myo-inositol is used to generate various phosphoinositide species involved in membrane trafficking, synapse formation, and signal transduction pathways regulating exocytosis and endocytosis. Disruption can impair these processes, potentially contributing to neurodevelopmental disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myo-inositol-dependent Neuronal Signalling.